Patent · US Active

Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith

US8158635B2 · kind B2 · utility

23Cited by

5References

4Claims

0Family size

Assignee

Signal Pharmaceuticals, LLC · US

Inventors

Marie Georges Beauchamps · Dover, US
Louise M. Cameron · Plainsboro, US
Robert Hilgraf · Cambridge, US
Mohit Atul Kothare · Bound Brook Junction, US
Manohar T. Saindane · Monmouth Junction, US
Jean Xu · Hackettstown, US

Key dates

Filing date	Aug 28, 2008
Grant date	Apr 17, 2012
Priority date	—
Expiry date	Mar 12, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-ylamino]-cyclohexan-1-ol, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.